Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate

European Journal of Clinical Investigation

Volumn 37, Issue 2, 2007, Pages 126-133

  Patrikainen, L ^a   Porvari, K ^a   Kurkela, R ^a   Hirvikoski, P ^b   Soini, Y ^a   Vihko, P ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Differential gene expression; Prostate cancer progression

Indexed keywords

ADENOSINE DERIVATIVE; ALPHA1 INTEGRIN; ASPARTATE AMMONIA LIGASE; COLLAGEN TYPE 6; COMPLEMENTARY DNA; FIBRONECTIN; FIBRONECTIN I; FORTILIN; HYPOCALCIN; MACROPHAGE INHIBITORY CYTOKINE 1; MESSENGER RNA; NAD DEPENDENT METHYLENE TETRAHYDRATE DEHYDROGENASE CYCLOHYDROLASE; PROTEIN DERIVATIVE; PROTEOHEPARAN SULFATE; SERINE PROTEASE 1; SERINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL ADHESION; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DNA MICROARRAY; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC TRANSCRIPTION; GLEASON SCORE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA ISOLATION;

BLOTTING, NORTHERN; CELL ADHESION; CELL LINE, TUMOR; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; MALE; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 33846047907     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01763.x     Document Type: Article

References (38)

1. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY et al. MIC-1, a novel macrophage inhibitory cytokine is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 1997;94:11514-9.
2. Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M et al. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 2006;66:4983-6.
3. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S et al. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 1998;273:13760-7.
4. Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML et al. The transforming growth factor-beta superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 2000;85:4781-8.
5. Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 1999;65:2-5.
6. Brown DA, Liu T, Ward RL, Hawkins NJ, Fairlie WD, Bauskin AR et al. Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia. J Leukoc Biol 2001;90:311.
7. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 2003;100:3410-5.
8. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003;9:2642-50.
9. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.
10. Gleason DF, Mellinger GT, the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 1974;111:58-64.
11. Kivinen A, Patrikainen L, Kurkela R, Porvari K, Vihko P. USF2 is connected to GAAAATATGATA element and associates with androgen receptor-dependent transcriptional regulation in prostate. Prostate 2004;59:190-202.
12. Chotteau-Lelievre A, Desbiens X, Pelczar H, Defossez PA, de Launoit Y. Differential expression patterns of the PEA3 group transcription factors through murine embryonic development. Oncogene 1994;5:937-52.
13. Mustonen M, Putanen M, Kellokumpu S, de Launoit Y, Isomaa V, Vihko R. Mouse 17β-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts. J Mol Endocrinol 1998;20:67-74.
14. Chu ML, Zhang RZ, Pan TC, Stokes D, Conway D, Kuo HJ et al. Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors. EMBO J 1990;9:385-93.
15. Zeichen J, van Griensven M, Lobenhoffer P, Boch U. Expression of type VI collagen in arthrofibrosis. An immunohistochemical study. Unfallchirurg 2000;103:640-4.
16. Kallunki P, Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein; a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Cell Biol 1992;116:559-71.
17. Donald CD, Montgomery DE, Emmet N, Cooke DB 3rd. Invasive potential and substrate dependence of attachment in the dunning R-3327 rat prostate adenocarcinoma model. Invasion Metastasis 1998;18:165-75.
18. Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem 2001;276:47542-9.
19. Sites CK, Kessel B, LaBarbera AR. Adhesion proteins increase cellular attachment, follicle-stimulating hormone receptors, and progesterone production in cultures porcine granulosa cells. Proc Soc Exp Biol Med 1996;212:78-83.
20. Briesewitz R, Epstein MR, Marcantonio EE. Expression of native and truncated forms of the human integrin alpha 1 subunit. J Biol Chem 1993;268:2989-96.
21. Vaarala M, Porvari K, Kyllönen A, Vihko P. Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 2000;80:1259-68.
22. Miyake H, Nelson C, Rennie PS, Gleave ME. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 2000;41:2257-65.
23. Liu AY, Corey E, Bladou F, Lange PH, Vessella RL. Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration. Int J Cancer 1996;65:85-9.
24. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000;6:2104-19.
25. Sharief FS, Mohler JL, Sharief Y, Li SS. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues. Biochem Mol Biol Int 1994;33:567-74.
26. Goldberg SF, Miele ME, Hatta N, Takata M, Paquette-Sraub C, Freedman L et al. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 2003;63:432-40.
27. Stams WA, den Boer ML, Holleman A, Appel IM, Beverloo HB, van Wering ER et al. Asparagine synthetase expression is linked with 1-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. Blood 2005;105:4223-5.
28. Takeuchi T, Shuman MA, Craik CS. Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 1999;96:11054-61.
29. Chang AC-M, Jellinek DA, Reddel RR. Mammalian stanniocalcins and cancer. Edocrine-Related Cancer 2003;10:359-73.
30. Baek SJ, Kim K-S, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2002;59:901-8.
31. Liu T, Bauskin AR, Zaunders J, Brown DA, Pankurst S, Russell RJ et al. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003;63:5034-40.
32. Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 2002;23:967-75.
33. Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF et al. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 2003;305:598-604.
34. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
35. Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K et al. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer 2003;88:1101-4.
36. Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC et al. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 2004;64:5929-33.
37. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M et al. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res 2005;65:2330-6.
38. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 2003;100:3410-5.